Iradimed (IRMD) Operating Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Operating Expenses data on file, last reported at $9.6 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $9.6 million, up 1.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.3 million (up 9.06% YoY), and the FY2025 annual result was $38.2 million, up 11.03% from the prior year.
• Operating Expenses eased to $9.6 million in Q1 2026 per IRMD's latest filing, from $9.9 million in the prior quarter.
• Over five years, Operating Expenses peaked at $9.9 million in Q4 2025 and troughed at $6.0 million in Q2 2022.
• A 5-year average of $8.1 million and a median of $8.4 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2026: Operating Expenses increased 22.36% in 2023, then increased 1.76% in 2026.
• A 5-year view of Operating Expenses shows it stood at $7.0 million in 2022, then climbed by 18.47% to $8.3 million in 2023, then increased by 8.57% to $9.0 million in 2024, then rose by 10.91% to $9.9 million in 2025, then fell by 3.63% to $9.6 million in 2026.
• Business Quant data shows IRMD's Operating Expenses at $9.6 million in Q1 2026, $9.9 million in Q4 2025, and $9.7 million in Q3 2025.